Pacific Biosciences Of California Cash Flow Statement (2010-2026) | PACB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-41.16M		-69.33M	-81.50M	-71.39M	-76.97M	-84.38M	-88.02M	-69.83M	-66.87M	-82.02M	-78.18M	-173.32M	-60.73M	2.37M	-426.07M	-41.93M	-38.00M	-40.37M	-8.28M
Depreciation and Depletion (Quarter)	1.59M		2.26M	2.27M	2.32M	2.35M	2.56M	2.75M	2.83M	2.90M	3.01M	3.24M	3.50M	4.19M	2.84M	5.13M	2.66M	2.46M	2.75M	2.20M
Share-based Compensation (Quarter)	15.80M	18.90M	18.94M	22.70M	19.02M	18.94M	17.95M	17.95M	17.89M	19.69M	16.58M	19.52M	17.22M	18.26M	16.03M	9.20M	11.89M	10.98M	9.59M	4.46M
Deferred Taxes (Quarter)			1.18M								-0.72M				-0.20M	-0.55M
Gains from Sales and Divestitures (Quarter)	1.49M		1.80M	1.84M	0.00M	2.40M	2.58M
Gains from Investment Securities (Quarter)	8.74M		12.16M	-0.10M	0.00M	4.28M	1.30M	12.26M	1.98M	-0.27M	-15.02M	-0.07M		1.17M	-1.95M	-0.72M			0.03M
Asset Writedowns and Impairment (Quarter)				0.39M	1.40M	0.88M	-2.67M	3.52M	0.77M	0.40M	-4.69M	0.00M	93.20M		36.28M	15.00M				0.05M
Non-cash Items (Quarter)			122.90M				125.10M
Cash from Operations (Quarter)	-15.71M		-31.71M	-79.03M	-60.56M	-63.05M	-60.57M	-94.69M	-41.74M	-65.18M	-57.56M	-75.68M	-54.26M	-45.46M	-30.65M	-44.06M	-29.38M	-18.71M	-19.07M	-44.69M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)													93.20M
Amortizatization of Intangibles (Quarter)	-1.22M		-0.90M	-0.76M	4.17M	-4.48M	1.31M	1.53M	-1.06M	0.94M	5.40M	4.03M	4.22M	3.65M	2.38M	1.71M	0.83M	0.83M	-364.06M	1.02M
Amortization of Deferred Charges (Quarter)	0.15M		0.16M	0.15M	0.15M	0.16M	0.16M	0.16M	0.15M
Depreciation & Amortization (CF) (Quarter)	1.59M		2.26M	2.27M	2.32M	2.35M	2.56M	2.75M	2.83M	2.90M	3.01M	3.24M	3.50M	4.19M	2.84M	5.13M	2.66M	2.46M	2.75M	2.20M
Change in Working Capital
Change in Receivables (Quarter)	7.03M		0.29M	3.61M	-0.79M	-4.30M	-3.97M	10.80M	-5.55M	6.45M	6.13M	-6.29M	2.11M	-3.05M	-1.86M	4.12M	0.61M	-1.64M	4.83M	-6.10M
Change in Inventory (Quarter)	2.47M		7.66M	6.66M	8.29M	8.41M	10.54M	13.32M	6.38M	3.15M	-9.01M	11.65M	5.11M	-1.37M	-7.07M	2.54M	1.33M	1.06M	-3.51M	3.21M
Change in Account Payables (Quarter)	1.25M		6.17M	6.37M	-5.04M	0.18M	-0.49M	5.07M	-0.81M	-2.56M	-1.50M	6.64M	-3.25M	-5.61M	3.63M	-1.52M	1.02M	1.27M	1.72M	-4.32M
Change in Accured Expenses (Quarter)	8.24M		-11.07M	-17.23M	17.61M	-11.43M	11.94M	-2.46M	-3.50M	8.01M	11.05M	-23.75M	22.66M	-5.96M	-19.29M	0.31M	-2.72M	0.19M	1.03M	5.13M
Other Working Capital Changes (Quarter)	-0.37M		0.59M	1.19M	-0.84M	-3.92M	15.90M	6.89M	-0.80M	-12.48M	-2.36M	-3.05M	-4.40M	5.62M	-3.10M	-3.43M	4.23M	-0.12M	-9.20M	2.29M
Investing Activities
Capital Expenditures (Quarter)	1.57M		2.84M	3.64M	4.02M	4.19M	4.90M	3.72M	2.27M	0.83M	2.02M	3.88M	1.48M	-0.79M	1.62M	1.39M	0.55M	-0.09M	0.86M	3.04M
Sales of Property, Plant and Equipment (Quarter)																				50.00M
Change in Intangibles (Quarter)																5.00M				5.00M
Acquisitions (Quarter)			291.23M
Change in Acquisitions & Divestments (Quarter)	29.96M		199.22M	122.06M	-122.06M	355.43M	-355.43M	0.59M	310.53M	320.12M	138.27M	161.65M	189.97M	-343.56M	26.80M	113.44M	82.00M	84.64M	-280.09M	48.25M
Cash from Investing Activities (Quarter)	-460.81M		65.75M	42.05M	-60.28M	53.91M	80.40M	-72.55M	-98.59M	242.32M	-66.58M	-34.14M	76.84M	23.07M	58.24M	45.23M	25.28M	18.90M	26.03M	35.86M
Financing Activities
Other financing activities (Quarter)	2.97M	5.20M	0.25M	5.59M	0.85M	3.54M				0.49M	0.05M
Cash from Financing Activities (Quarter)	2.88M		1.32M	5.21M	0.46M	3.13M	0.82M	195.99M	-4.71M	-0.78M	-81.60M	6.55M	-0.15M	0.81M	-50.20M	1.96M		1.47M		1.44M
Additional items
Change in Cash (Quarter)	-473.64M		35.37M	-31.76M	-120.39M	-6.01M	20.66M	28.75M	-145.05M	176.36M	-205.74M	-103.27M	22.42M	-21.59M	-22.61M	3.14M	-4.09M	1.66M	6.96M	-7.39M
Free Cash Flow (Quarter)	-17.28M		-34.55M	-82.67M	-64.58M	-67.24M	-65.47M	-98.41M	-44.01M	-66.01M	-59.58M	-79.56M	-55.74M	-44.68M	-32.27M	-45.45M	-29.93M	-18.62M	-19.93M	-47.73M
Net Cash Flow (Quarter)	-473.64M		35.37M	-31.76M	-120.39M	-6.01M	20.66M	28.75M	-145.05M	176.36M	-205.74M	-103.27M	22.42M	-21.59M	-22.61M	3.14M	-4.09M	1.66M	6.96M	-7.39M

Research Tools

Pacific Biosciences Of California Cash Flow Statement (2010-2026) | PACB

Create an account

Sign In

Reset Password